| Metric | Q1 2026 | Q4 2025 | Q1 2025 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $617M | — | — | — | — |
| Op. Income | $17M | — | — | — | — |
| Gross Margin | 30.9% | — | — | — | — |
| Net Margin | 1.1% | — | — | — | — |
| EPS (Diluted) | $0.11 | — | — | — | — |
| Free Cash Flow | -$81M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $617M |
| Cost of Revenue | $427M |
| GROSS PROFIT | $191M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $174M |
| Other Expenses | $0 |
| Operating Expenses | $174M |
| Cost & Expenses | $601M |
| OPERATING INCOME | $17M |
| Interest Income | $7M |
| Interest Expense | $15M |
| Other Income/Expenses | -$8M |
| INCOME BEFORE TAX | $9M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $7M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $7M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $7M |
| D&A | $21M |
| EBIT | $23M |
| EBITDA | $44M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $617M |
| Cost of Revenue | $427M |
| GROSS PROFIT | $191M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $174M |
| Other Expenses | $0 |
| Operating Expenses | $174M |
| Cost & Expenses | $601M |
| OPERATING INCOME | $17M |
| Interest Income | $7M |
| Interest Expense | $15M |
| Other Income/Expenses | -$8M |
| INCOME BEFORE TAX | $9M |
| Income Tax Expense | $2M |
| Net Income from Continuing Ops | $7M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $7M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $7M |
| D&A | $21M |
| EBIT | $23M |
| EBITDA | $44M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $7M |
| Depreciation & Amortization | $21M |
| Stock-Based Compensation | $5M |
| Deferred Income Tax | $2M |
| Other Non-Cash Items | $5M |
| Change in Working Capital | -$109M |
| OPERATING CASH FLOW | -$70M |
| Capital Expenditure | -$11M |
| Acquisitions (Net) | -$57M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$68M |
| Net Debt Issuance | -$15M |
| Common Stock Repurchased | -$20M |
| Common Dividends Paid | $0 |
| Other Financing Activities | $12M |
| NET CASH FROM FINANCING | -$23M |
| FREE CASH FLOW | -$81M |
| Net Change in Cash | -$161M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $721M |
| Short-Term Investments | $0 |
| Net Receivables | $358M |
| Inventory | $836M |
| Other Current Assets | $50M |
| TOTAL CURRENT ASSETS | $2.0B |
| PP&E (Net) | $564M |
| Goodwill | $555M |
| Intangible Assets | $441M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $118M |
| TOTAL NON-CURRENT ASSETS | $1.7B |
| TOTAL ASSETS | $3.6B |
| Account Payables | $264M |
| Short-Term Debt | $53M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $257M |
| TOTAL CURRENT LIABILITIES | $574M |
| Long-Term Debt | $1.4B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | -$61M |
| TOTAL NON-CURRENT LIABILITIES | $1.5B |
| TOTAL LIABILITIES | $2.1B |
| Common Stock | $607.0K |
| Additional Paid-In Capital | $569M |
| Retained Earnings | $1.0B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$3M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.6B |
| Minority Interest | $544.0K |
| TOTAL EQUITY | $1.6B |
| TOTAL LIABILITIES & EQUITY | $3.6B |
| Total Debt | $1.6B |
| Net Debt | $886M |
